South Korea · Delayed Price · Currency is KRW Hancom Lifecare Statistics
Total Valuation
Hancom Lifecare has a market cap or net worth of KRW 57.15 billion. The enterprise value is 18.03 billion.
| Market Cap | 57.15B |
| Enterprise Value | 18.03B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hancom Lifecare has 27.67 million shares outstanding.
| Current Share Class | 27.67M |
| Shares Outstanding | 27.67M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 14.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 9.04 |
| PS Ratio | 0.48 |
| PB Ratio | 0.43 |
| P/TBV Ratio | 0.44 |
| P/FCF Ratio | 3.78 |
| P/OCF Ratio | 2.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.78, with an EV/FCF ratio of 1.19.
| EV / Earnings | n/a |
| EV / Sales | 0.15 |
| EV / EBITDA | 7.78 |
| EV / EBIT | n/a |
| EV / FCF | 1.19 |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.00.
| Current Ratio | 1.95 |
| Quick Ratio | 0.81 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.02 |
| Interest Coverage | -149.12 |
Financial Efficiency
Return on equity (ROE) is -0.24% and return on invested capital (ROIC) is -2.47%.
| Return on Equity (ROE) | -0.24% |
| Return on Assets (ROA) | -0.73% |
| Return on Invested Capital (ROIC) | -2.47% |
| Return on Capital Employed (ROCE) | -1.68% |
| Weighted Average Cost of Capital (WACC) | 5.77% |
| Revenue Per Employee | 574.10M |
| Profits Per Employee | -1.95M |
| Employee Count | 208 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 2.09 |
Taxes
In the past 12 months, Hancom Lifecare has paid 169.67 million in taxes.
| Income Tax | 169.67M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.73% in the last 52 weeks. The beta is 0.28, so Hancom Lifecare's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -26.73% |
| 50-Day Moving Average | 1,783.90 |
| 200-Day Moving Average | 2,372.89 |
| Relative Strength Index (RSI) | 76.08 |
| Average Volume (20 Days) | 644,736 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hancom Lifecare had revenue of KRW 119.41 billion and -406.36 million in losses. Loss per share was -15.00.
| Revenue | 119.41B |
| Gross Profit | 26.50B |
| Operating Income | -2.25B |
| Pretax Income | -150.08M |
| Net Income | -406.36M |
| EBITDA | 2.32B |
| EBIT | -2.25B |
| Loss Per Share | -15.00 |
Balance Sheet
The company has 40.19 billion in cash and 373.35 million in debt, with a net cash position of 39.82 billion or 1,438.77 per share.
| Cash & Cash Equivalents | 40.19B |
| Total Debt | 373.35M |
| Net Cash | 39.82B |
| Net Cash Per Share | 1,438.77 |
| Equity (Book Value) | 132.29B |
| Book Value Per Share | 4,755.28 |
| Working Capital | 54.56B |
Cash Flow
In the last 12 months, operating cash flow was 21.55 billion and capital expenditures -6.42 billion, giving a free cash flow of 15.14 billion.
| Operating Cash Flow | 21.55B |
| Capital Expenditures | -6.42B |
| Depreciation & Amortization | 4.57B |
| Net Borrowing | -102.37M |
| Free Cash Flow | 15.14B |
| FCF Per Share | 546.94 |
Margins
Gross margin is 22.19%, with operating and profit margins of -1.89% and -0.34%.
| Gross Margin | 22.19% |
| Operating Margin | -1.89% |
| Pretax Margin | -0.13% |
| Profit Margin | -0.34% |
| EBITDA Margin | 1.94% |
| EBIT Margin | -1.89% |
| FCF Margin | 12.68% |
Dividends & Yields
Hancom Lifecare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.71% |
| FCF Yield | 26.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Hancom Lifecare has an Altman Z-Score of 2.77 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.77 |
| Piotroski F-Score | 3 |